What's Happening?
K.C. Pharmaceuticals, Inc., based in Pomona, California, has voluntarily recalled over 3.1 million bottles of eye drops distributed nationwide. The recall was initiated on March 3, 2026, following concerns about the sterility of the products. The U.S.
Food and Drug Administration (FDA) has classified the recall as Class II, indicating that use of or exposure to the product may cause temporary or medically reversible adverse health consequences, with the probability of serious health effects considered remote. The affected products were sold under multiple brand names through major retailers such as Walgreens, Kroger, CVS, and others. The recall includes various types of eye drops, such as Sterile Eye Drops AC, Eye Drops Advanced Relief, and Dry Eye Relief Eye Drops, among others.
Why It's Important?
The recall of over-the-counter eye drops is significant due to the potential health risks associated with non-sterile products. Eye drops are commonly used for various eye conditions, and compromised sterility can lead to infections or other adverse health effects. The recall impacts consumers nationwide, highlighting the importance of product safety and quality assurance in pharmaceuticals. Retailers and consumers must be vigilant in checking product labels and lot numbers to avoid using affected products. The recall also underscores the role of the FDA in monitoring and ensuring the safety of consumer health products.
What's Next?
The recall remains ongoing, with no termination date listed. Consumers are advised to check product labels, lot numbers, and expiration dates to determine if they have purchased any of the recalled eye drops. The FDA continues to monitor the situation, and further updates may be provided as the recall progresses. Retailers are expected to remove affected products from shelves and notify customers. K.C. Pharmaceuticals may issue additional communications to address consumer concerns and provide guidance on returning or disposing of recalled products.
